Pharmaceutical Company Agrees to Pay $3.5 Million to Resolve Allegations of Violating False Claims Act
NEWARK, N.J. - Pacira Pharmaceuticals Inc. will pay $3.5 million to resolve allegations that it paid kickbacks to doctors in the form of bogus research grants to induce them to prescribe its analgesic EXPAREL, Attorney for the United States Rachael A. Honig announced today. The allegations arose from a whistleblower suit filed under the False Claims Act.
- Date:July 28, 2020
- Agency:U.S. Attorney's Office, District of New Jersey
- Criminal and Civil Actions